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The literature is clear that the diagnosis, treatment, and plan of care for hypertension in 
adults should rely, at least in part, on ambulatory blood pressure. Using in-office blood pressures 
alone risks inaccurate measurements and can result in inappropriate treatments. Many clinics, 
however, do not adhere to this recommendation and will fall back on clinic readings which puts 
the patient at risk of mismanaged hypertension and polypharmacy. This project was formulated 
to identify the extent to which hypertensive patients were diagnosed and managed without the 
use of home blood pressure monitoring in a small local community clinic. This project will also 
explore and identify sources for low-to-no cost at-home monitors for patient use. The hope is that 
this project will encourage a future project to initiate routine home blood pressure monitoring for 
hypertensive patients at this clinic to improve adherence to evidence-based practice. 
Keywords: white coat hypertension, ambulatory blood pressure, home blood pressure, 




Identifying Opportunities for Implementing Home Blood Pressure Monitoring in Newly 
Diagnosed or Worsening Hypertension at a Family Health Clinic 
Hypertension is a relatively simple disease. Its diagnosis does not require expensive tests 
or imaging and the treatments options include some of the cheapest drugs available. Its relative 
simplicity, however, belies the complexity and severity the condition can have on the human 
body. 
Affecting close to half of the adult population in the United States, hypertension’s hold 
on the country cannot be understated (Center for Disease Control, 2020). It is silent, insidious, 
and deadly, and though relatively simple in its pathophysiology, mainly increased arterial 
pressure in the blood vessels of the body, hypertension can be stubborn to treat. Aside from 
being exceedingly common, chronic hypertension can have significant lasting effects on a 
person’s health. Not only is hypertension the primary or contributory factor in the deaths of 
nearly half a million Americans every year (Center for Disease Control, 2020), but it is also the 
most important modifiable risk factor in premature deaths worldwide as reported by the World 
Health Organization in 2009. In 2010 alone it was reported to have been a factor in 18% or 9.4 
million deaths worldwide (Campbell et al., 2015). Chronically elevated blood pressure can have 
system wide effects ranging from stroke, cardiovascular disease, renal disease, some forms of 
dementia, and retinopathy, conditions that affect millions. 
Historically, hypertension was not considered a disease until the early 1800’s, less than a 
hundred years after blood pressure was first identified as a measurement of the body’s vital 
function (Kotchen, 2011). Essential hypertension, the name for elevated blood pressure without a 
primary cause, was coined in the early 20th century making the diagnosis fairly new in the 
lexicon of human disease (Esunge, 1991). It took until the middle of the 1900’s before treatment 
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was even considered for “mild” hypertension (blood pressures below 210/100 mmHg) (Moser, 
2006) (Pickering, 1952). Around the same time diuretics were discovered, heralding a new era of 
improved cardiovascular health. It is presumed that the 50% decrease in stroke and ischemic 
heart disease between 1972 and 1994 was at least partially due to the subsequent treatment of 
hypertension (Dustan, Roccella, & Garrison, 1996). 
Today hypertension is diagnosed and treated far more liberally. Systolic blood pressure 
readings routinely above 120mmHg are now considered elevated and a formal diagnosis of 
hypertension is made when they are above 130mmHg, a far cry from the 200s range required in 
the 20th century. Treatment typically starts slowly with lifestyle changes such as weight loss, 
exercise, and reduced sodium intake. Medications such as diuretics, calcium channel blockers, 
angiotensin II receptor blockers, and angiotensin converting enzyme inhibitors are often added 
later if lifestyle changes are unable to make a significant dent in readings. 
 Simple to diagnose and usually simple to treat, hypertension has become a one of 
the most frequently seen conditions in the primary care clinic and it is often easily managed by 
most general clinicians. There is, however, always room for improvement. This project will 
serve to highlight one clinic’s deviation from recommended practice and how it might be 
encouraged to follow guidelines to better manage this common but potentially serious condition. 
Purpose 
Currently, a small adult general medicine clinic in Southern California provides 
hypertension diagnoses and bases treatment plans on attended blood pressure measurements 
taken at the clinic. The provider does not routinely rely on home measurements for the diagnosis 
or treatment of hypertension. Most, if not all, patients are diagnosed and treated based on isolated 
elevated measurements obtained in-office. This project was created with the purpose of 
identifying just how extensive the use of in-office blood pressures is at this particular clinic for 
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hypertensive patients and whether this is a significant defect in following evidence-based 
guidelines that would benefit from a change in practice. This project is a stepping-stone created 
to identify an opportunity for a future project to encourage the practice of using home blood 
pressure monitoring at this location. It did not serve to implement a change in practice, only to 
establish the need for a practice change. 
This original purpose of this project was to prove the existence of and better recognize 
falsely elevated in-clinic blood pressure, also called White Coat Hypertension, and to create a 
plan around managing the condition. In practice, however, finding enough patients who fit that 
criteria as well as designing a treatment plan would have required time and dedication this 
project could not muster. And so, the plan was revised and devised to essentially encourage 
evidenced-based practice in the ambulatory clinic by highlighting an opportunity for change.  
Evidence for Problem 
A review of literature was completed using the following search engines: Cochrane, PubMed, 
and CINAHL. Keywords utilized with each search engine were hypertension, 
diagnosis/treatment/management of hypertension, ambulatory blood pressure, in-office blood 
pressure, and White Coat Hypertension. This search yielded over 242 articles from the past 5 
years from peer-reviewed publications. Articles were ranked based on the rigor of the study with 
priority taken for meta-analyses. Policies and guidelines for large organizations and public health 
centers nationally and internationally were also included in the research as sources of evidence. 
Most major organizations for cardiovascular health including the American Heart 
Association (AHA) and the American College of Cardiology (ACC) follow the “Guideline for 
the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults” 
created by the ACC/AHA task force in 2017. This guideline outlines the current recommended 
practice for diagnosing hypertension which requires a resting systolic blood pressure average at 
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or above 130mmHg from 2-3 measurements taken over 2-3 separate occasions while the patient 
is at rest and on a chair. Measurements above 120mmHg are considered “elevated” but are not 
quite high enough for a formal diagnosis. Once consistently above 130mmHg the diagnosis is 
divided into two stages: stage I for average measurements between 130-140mmHg and stage II 
for average measurements above 140mmHg.  
The 2020 International Society of Hypertension Global Hypertension Practice Guidelines 
offers another perspective on how providers diagnose and manage patients outside of the United 
States. This guideline differs slightly from the American guideline by classifying hypertension as 
systolic blood pressures equal or above 140mmHg or diastolic blood pressures equal or above 
90mmHg, but like its American counterpart, it recommends averaging results over 2-3 separate 
visits as opposed to separate occasions (Unger et al. 2020). 
One key recommendation that all medical powerhouses agree on is that the diagnosis of 
hypertension should rely more on multiple unattended or home blood pressure measurements 
rather than on single, attended, infrequent measurements taken in-office. It is preferred to utilize 
ambulatory or home measurements to confirm the diagnosis as it is often lower than in-clinic 
measurements with an average of a 5-point decrease (Keely, 2020). It is even noted in the 2020 
International Society of Hypertension Global Hypertension Practice Guidelines that blood 
pressure cut-offs for the diagnosis of hypertension depend on the source of the results. 
Ambulatory blood pressure readings have a threshold of diagnosis 5 points lower than that of 
readings taken in the office (Unger, 2020). This difference can even be found in unattended 
measurements (wherein the patient has their vitals taken during an office visit without the 
presence of a staff member). The use of unattended, ambulatory blood pressure readings is vital 
because it is more accurate and is more accurately tied with an increased risk of death and 
cardiovascular heart disease and stroke compared to readings taken in the clinic (Whelton et al., 
2017). Not only does home blood pressure monitoring make a difference in diagnosis, it also has 
been shown to improve adherence to treatment and thereby improving hypertension control rates 
overall (Stergiou et al., 2014). It also important to note that treating patients who are diagnosed 
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with hypertension based solely on elevated blood pressure in the clinic, also called White Coat 
Hypertension, did not reduce the risk of cardiovascular events (Xiang, 2020). This highlights the 
importance of identifying whether a patient has consistently elevated blood pressure that could 
benefit from antihypertensives or whether they just have transient hypertension that may be 
unaffected by medication. 
Medicare has attempted to addresses the issue of false hypertension by covering the use 
of a yearly “Ambulatory Blood Pressure Device”. This device is a small instrument worn on the 
arm that will take blood pressure measurements at different intervals during a full 24- or 48-hour 
period, creating a more accurate picture of a patient’s usual blood pressure on a given day. It can 
be ordered by a provider for patients with suspected White Coat Hypertension or Masked 
Hypertension, in which the blood pressure is normally higher than what is seen in the office 
(AARP Medical Plans, n.d.). This device differs from the more commonly seen “home blood 
pressure monitor” that can be purchased at any pharmacy over the counter and needs to be 
applied and operated to take a single blood pressure measurement at a chosen moment. Though it 
produces a more accurate and detailed log of a patient’s typical blood pressure, the Ambulatory 
Blood Pressure Device, is cumbersome and inconvenient, most physicians and patients are 
disinclined to use it. The over-the-counter option is preferred in most cases instead. 
Framework 
The decision to choose the 8A’s framework was originally chosen as it is a San Diego 
native EBP model. Created in 2007 by Carolyn Brown EdD, RN and Laurie Ecoff PhD, RN for 
the San Diego Evidence-Based Practice Consortium, the model was adapted from an earlier EBP 
model formulated by Mary Ann Rossworm and June Larrabee (Brown & Ecoff, 2011). This 
framework was built in order to better formulate a streamlined process in which to establish 
evidence-based change in practice.  
The 8A’s EBP model begins by identifying a “Catalyst” which is the original reason 
behind the project and is followed by “Assessing” which, as the name implies, is the process of 
investigating the extent of the problem and how much of a “problem” it is. The model continues 
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with “Asking” in which the PICOT (Population, Intervention, Comparison, Timeline) question is 
formulated then “Acquiring” and “Appraising” which involves acquiring the evidence that 
supports the change and appraising the quality of the research and evidence found. Finally, the 
evidence is implemented or “applied” in the “Application” stage and the project truly gets 
underway. Once implemented and the timeline is reached, the project outcomes are “Analyzed” 
at which point the project is at the final stage: “Advancing and Adopting” wherein the results are 
published and disseminated to spread change outside the confines of the original project. 
 It was really the “Assessing” stage that this project was developed for. Its purpose was 
not to create a practice change but rather to identify the need for one.  
Figure 1 
San Diego’s 8A’s Evidence-Based Practice Model 
 
Note. This figure lists the 8A’s stages to follow in order to implement an EBP change.  
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Project Plan Process 
As it was discovered that this clinic does not routinely utilize the recommendations of 
home blood pressure monitoring it was decided to center this project around examining the true 
extent of hypertension diagnosed at the clinic to determine if this change in practice 
recommendations was likely to have a significant effect on a large percentage of its patient 
population. The project also served to identify which patients diagnosed with hypertension could 
qualify for a covered ambulatory monitoring device and whether this is a significant percentage 
of the patient population seen at this clinic. 
Patients whose blood pressure when taken in the office was above 130mmHg systolic 
were included in the project and their demographics were recorded including their age, biological 
sex, stated race or ethnicity, previous blood pressure readings, history of hypertension or 
diabetes, and whether they were currently on blood pressure medication. Lastly, their insurance 
information was also recorded to establish whether they would be entitled to free home 
monitoring. 
Assessment of Findings 
Out of 75 patients whose records were examined, 50 presented with an elevated blood 
pressure based on their blood pressure readings at the time of their visit. Those 50 patients were 
included in the project and their data was subsequently collected. The information was extracted 
from visits during the last two weeks of November where approximately 10 patients were seen 
per day except for Wednesdays which had 5 patients for a rough total of 220 patients seen over 
two weeks. The overwhelming majority of patients in any given day had blood pressure readings 
above SBP 130, in fact typically only 1-3 patients per day had a normal blood pressure reading. 
Save for a handful of patients who had taken matters into their own hands, most also did not 
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regularly check their blood pressure at home so a true baseline was not established. None of the 
patients had been offered to use a home blood pressure monitoring system or an ambulatory 
blood pressure device to more accurately diagnosed and rate their hypertension even though 
every Medicare patient seen qualified for one of these devices. 
Of the 50 patients identified, over half (52%) presented with a reading above 140mmHg 
and 10% had systolic blood pressures exceeding 180mmgHg which qualified them for a 
diagnosis of hypertension based on that single reading alone (Whelton et al., 2017). Many of the 
patients (40%) were at or above the age of 65, when Medicare coverage may potentially apply. 
Ages ranged from 21 - 92 years and the group was divided pretty evenly amongst gender lines 
(24 women and 26 men). Half were of Hispanic or Latino ethnicity, 19 were Caucasian, 4 were 
of an unstated race, and 2 were Asian. 
Of the patients seen, 19 had Medicare or a Medicare Replacement/Advantage plan which 
would cover the yearly ambulatory device (AARP Medical Plans, n.d.) and 11 had Medicaid or 
Medicaid Replacement/Advantage which covers a home device but only for malignant 
hypertension or end-stage renal disease (California Health and Wellness, n.d.).  
Of the 50 patients seen with an elevated in-office blood pressure, 32 had a history of 
hypertension, 2 of which were not being treated with medication, 3 did not have a history of 
diagnosed hypertension but had been prescribed anti-hypertensives. 17 had a comorbidity of 
diabetes mellitus as well, while 5 had diabetes but no history hypertension, and 12 had no history 





Blood Pressure Stages 
 
Note. The division of blood pressure stages based on the patient’s initial reading. 
Figure 3  
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Cost/Benefit Analysis for Sustainability of Project: 
The cost of hypertension cannot be ignored, both as a cost to the individual with the 
diagnosis and to the country at large. The increase in annual healthcare costs for patients with 
hypertension is significant at $2,000 and the costs for hypertension as a disease in the United 
States is $131 billion (Kirkland, 2018).  
By implementing this project patients may save up to $2,000 annually. For every dollar 
spent $200 will be saved for the patient. CBA= (benefits) $2,000/(cost) $100= $200, making the 
return of investment is 1,900%. ROI= {($2,000-$100)/$100}x100=1,900%. 
Table 1 
Cost/Benefit Analysis 
Costs – Utilizing home blood pressure 
monitors 
Costs – Continuing with in-office blood 
pressure readings alone 
Financial Non-Financial Financial Non-Financial 
-$0-100 per unit per 
patient depending on 
insurance coverage 


















-Potential saving up to $2,000 annually 
per patient who can avoid a diagnosed of 
hypertension 
-Decrease in polypharmacy and 




Implications for Practice 
 Implementing this project will require buy-in from the clinic staff and from the patients 
themselves. It will change the entire process of diagnosing and treating hypertension that is in 
place at the clinic now. This change can only be successful if the participants give it their best 
effort. It will also require more maintenance and surveillance to assure the accuracy of each 
induvial home monitor. As with some other practices, such as more specialized cardiology 
clinics, this office should implement the use of manual blood pressure devices in order to prevent 
technological errors or variances. This practice however requires training of staff and runs the 
risk of variances in readings due to human error. 
Conclusions 
The results of this project will hopefully show that there is a great opportunity for 
implementing home blood pressure monitoring to establish a more accurate picture of a patient’s 
condition and better identify tailored treatment options and care plans. This will also integrate 
the patient into their own healthcare and make them a more active participant in their health.  
It should be noted that this project is limited to the office in which it was conducted and 
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